MENU
+Compare
ENTX
Stock ticker: NASDAQ
AS OF
Dec 12 closing price
Price
$2.16
Change
-$0.05 (-2.26%)
Capitalization
99.05M

ENTX Entera Bio Ltd Forecast, Technical & Fundamental Analysis

Entera Bio Ltd is a clinical-stage biopharmaceutical company engaged in the development of orally delivered macromolecule therapeutics, including peptides and therapeutic proteins... Show more

ENTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for ENTX with price predictions
Dec 11, 2025

ENTX in downward trend: price dove below 50-day moving average on November 26, 2025

ENTX moved below its 50-day moving average on November 26, 2025 date and that indicates a change from an upward trend to a downward trend. In of 43 similar past instances, the stock price decreased further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 13, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on ENTX as a result. In of 90 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for ENTX turned negative on November 13, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 10-day moving average for ENTX crossed bearishly below the 50-day moving average on December 03, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ENTX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for ENTX entered a downward trend on December 11, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where ENTX's RSI Indicator exited the oversold zone, of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where ENTX advanced for three days, in of 233 cases, the price rose further within the following month. The odds of a continued upward trend are .

ENTX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. ENTX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.502) is normal, around the industry mean (28.362). P/E Ratio (0.000) is within average values for comparable stocks, (51.986). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.836). Dividend Yield (0.000) settles around the average of (0.049) among similar stocks. P/S Ratio (769.231) is also within normal values, averaging (336.196).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ENTX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
ENTX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

ENTX is expected to report earnings to fall 257.14% to -10 cents per share on March 27

Entera Bio Ltd ENTX Stock Earnings Reports
Q4'25
Est.
$-0.11
Q3'25
Beat
by $0.16
Q2'25
Beat
by $0.05
Q1'25
Beat
by $0.01
Q4'24
Est.
$-0.06
The last earnings report on November 14 showed earnings per share of 7 cents, beating the estimate of -9 cents. With 95.81K shares outstanding, the current market capitalization sits at 99.05M.
A.I. Advisor
published General Information

General Information

a manufacturer of flu medicines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Minrav Building - Fifth Floor
Phone
+972 25327151
Employees
19
Web
https://www.enterabio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BNXAF0.940.03
+3.29%
Banxa Holdings Inc.
JAGGF5.280.16
+3.22%
Jaguar Mining Inc.
ANSLY96.27N/A
N/A
Ansell Ltd.
ASBRF11.38N/A
N/A
Asahi Group Holdings Ltd.
HMTC4.45N/A
N/A
Homasote Co.

ENTX and Stocks

Correlation & Price change

A.I.dvisor tells us that ENTX and JSPR have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ENTX and JSPR's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ENTX
1D Price
Change %
ENTX100%
+4.25%
JSPR - ENTX
32%
Poorly correlated
-1.60%
WVE - ENTX
32%
Poorly correlated
-17.20%
XENE - ENTX
31%
Poorly correlated
+0.51%
OPORF - ENTX
31%
Poorly correlated
N/A
MLTX - ENTX
30%
Poorly correlated
-3.70%
More